DIETARY SUPPLEMENT LAW's "UNREASONABLE RISK" CLAUSE OPENS DOOR FOR FDA
This article was originally published in The Tan Sheet
Executive Summary
DIETARY SUPPLEMENT LAW's "UNREASONABLE RISK" CLAUSE OPENS DOOR FOR FDA to "attack and remove any products" from the market, attorney Milton Bass (New York law firm Bass & Ullman) states in an analysis of the new Dietary Supplement Health & Education Act ("The Tan Sheet" Oct. 31, p. 1). Under the act, in proving a dietary supplement is unsafe, FDA must show the product presents "an unreasonable risk." According to Bass, in evaluating whether a product has "any value or usefulness," FDA may decide it does not have value or usefulness and conclude that "any possible risk is unreasonable."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: